Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Sep;102(Suppl 3):247–250. doi: 10.1289/ehp.94102s3247

Protective effects of thiol compounds on chromate-induced toxicity in vitro and in vivo.

N Susa 1, S Ueno 1, Y Furukawa 1
PMCID: PMC1567400  PMID: 7843107

Abstract

The effects of thiol compounds (L-cysteine ethyl ester, 2,3-dimercaptosuccinic acid, or 2,3-dimercapto-1-propanesulfonic acid) on the toxicity induced by chromate (potassium dichromate) were investigated in HeLa cells and mice. Chromate-induced cytotoxicity evaluated by inhibition of cell growth and chromium content of the cells was diminished by all of the thiol compounds tested when the cells were incubated in the medium with both chromate and one of the thiol compounds. In mice injected ip with a thiol compound immediately after injection of chromate, mortality, ornithine carbamyl transferase activity in the serum, and chromium content in the liver were diminished remarkably compared with mice injected with chromate alone. These thiol compounds also caused an increase of urinary chromium excretion. These results suggest that the thiol compounds tested are useful for treating chromate-induced toxicity when they are given immediately after intake of the metal.

Full text

PDF
247

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen O., Nielsen J. B. Oral cadmium chloride intoxication in mice: effects of penicillamine, dimercaptosuccinic acid and related compounds. Pharmacol Toxicol. 1988 Nov;63(5):386–389. doi: 10.1111/j.1600-0773.1988.tb00973.x. [DOI] [PubMed] [Google Scholar]
  2. Basinger M. A., Jones M. M., Holscher M. A., Vaughn W. K. Antagonists for acute oral cadmium chloride intoxication. J Toxicol Environ Health. 1988;23(1):77–89. doi: 10.1080/15287398809531095. [DOI] [PubMed] [Google Scholar]
  3. Friedheim E., Corvi C. Meso-dimercaptosuccinic acid, a chelating agent for the treatment of mercury poisoning. J Pharm Pharmacol. 1975 Aug;27(8):624–626. doi: 10.1111/j.2042-7158.1975.tb09522.x. [DOI] [PubMed] [Google Scholar]
  4. GRAY S. J., STERLING K. The tagging of red cells and plasma proteins with radioactive chromium. J Clin Invest. 1950 Dec;29(12):1604–1613. doi: 10.1172/JCI102403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gabard B. Treatment of methylmercury poisoning in the rat with sodium 2,3-dimercaptopropane-i-sulfonate: influence of dose and mode of administration. Toxicol Appl Pharmacol. 1976 Nov;38(2):415–424. doi: 10.1016/0041-008x(76)90148-4. [DOI] [PubMed] [Google Scholar]
  6. Susa N. Antagonistic effect of DL-penicillamine of chromium toxicity in HeLa cells. Nihon Juigaku Zasshi. 1984 Feb;46(1):89–98. doi: 10.1292/jvms1939.46.89. [DOI] [PubMed] [Google Scholar]
  7. Susa N., Ueno S., Furukawa Y., Sunaga S., Taruta Y., Sato K. Effect of combined administration of DL-penicillamine and potassium dichromate on lethality, distribution and excretion of chromium in mice. Kitasato Arch Exp Med. 1988 Apr;61(1):51–57. [PubMed] [Google Scholar]
  8. Toohey J. I. Sulfhydryl dependence in primary explant hematopoietic cells. Inhibition of growth in vitro with vitamin B12 compounds. Proc Natl Acad Sci U S A. 1975 Jan;72(1):73–77. doi: 10.1073/pnas.72.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES